H1-RNF2-KO-2#
WAe001-A-42
General#
Cell Line |
|
| hPSCreg Name | WAe001-A-42 |
| Alternative name(s) |
H1-RNF2-KO-2#
|
| Cell line type | Human embryonic stem cell (hESC) |
| Last update | 17th March 2020 |
| User feedback | |
Provider |
|
| Generator | Nanfang Hospital, Southern Medical University (NFYY) |
| Owner | Nanfang Hospital, Southern Medical University (NFYY) |
| Distributors | |
| Derivation country | China |
External Databases |
|
| BioSamples | SAMEA123456 |
General Information |
|
| * Is the cell line readily obtainable for third parties? |
Yes Research: allowed
Clinical: not allowed
Commercial: not allowed
|
| Subclone of | |
Donor Information#
General Donor Information |
|
| Sex | male |
Phenotype and Disease related information (Donor) |
|
| Diseases | No disease was diagnosed.
|
Other Genotyping (Donor) |
|
| Is there genome-wide genotyping or functional data available? |
No
|
Donor Relations |
|
| Other cell lines of this donor | |
External Databases (Donor) |
|
| BioSamples | SAMEA7767418 |
Ethics#
Also have a look at the ethics information for the parental line
WAe001-A
.
hESC Derivation#
| Date of derivation | 2016-06-30 |
| Supernumerary embryos from IVF treatment? |
Yes
Separation of research and IVF treatment?
Yes |
| PGD Embryo? |
No |
Culture Conditions#
| Medium |
mTeSR™ 1
|
Characterisation#
No characterisation data could be found for this subclone. Please open parental cell line WAe001-AGenotyping#
Karyotyping (Cell Line) |
|
Other Genotyping (Cell Line) |
Genetic Modification#
| Genetic modifications not related to a disease |
|
Login to share your feedback, experiences or results with the research community.